NO883554L - Fremgangsmaate til isolering av basiske proteiner fra proteinblandinger som inneholder slike basiske proteiner. - Google Patents

Fremgangsmaate til isolering av basiske proteiner fra proteinblandinger som inneholder slike basiske proteiner.

Info

Publication number
NO883554L
NO883554L NO88883554A NO883554A NO883554L NO 883554 L NO883554 L NO 883554L NO 88883554 A NO88883554 A NO 88883554A NO 883554 A NO883554 A NO 883554A NO 883554 L NO883554 L NO 883554L
Authority
NO
Norway
Prior art keywords
basic proteins
isolation
procedure
ingredients containing
protein ingredients
Prior art date
Application number
NO88883554A
Other languages
English (en)
Other versions
NO175004C (no
NO883554D0 (no
NO175004B (no
Inventor
Michael Doerschug
Rainer Obermeier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO883554D0 publication Critical patent/NO883554D0/no
Publication of NO883554L publication Critical patent/NO883554L/no
Publication of NO175004B publication Critical patent/NO175004B/no
Publication of NO175004C publication Critical patent/NO175004C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO883554A 1987-08-11 1988-08-10 Fremgangsmåte til isolering av basiske insuliner fra proteinblandinger som inneholder slike basiske insuliner NO175004C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873726655 DE3726655A1 (de) 1987-08-11 1987-08-11 Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten

Publications (4)

Publication Number Publication Date
NO883554D0 NO883554D0 (no) 1988-08-10
NO883554L true NO883554L (no) 1989-02-13
NO175004B NO175004B (no) 1994-05-09
NO175004C NO175004C (no) 1994-08-17

Family

ID=6333496

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883554A NO175004C (no) 1987-08-11 1988-08-10 Fremgangsmåte til isolering av basiske insuliner fra proteinblandinger som inneholder slike basiske insuliner

Country Status (19)

Country Link
US (1) US5101013A (no)
EP (1) EP0305760B1 (no)
JP (1) JP2587867B2 (no)
KR (1) KR0129539B1 (no)
AT (1) ATE96447T1 (no)
AU (1) AU609170B2 (no)
CA (1) CA1340237C (no)
DE (2) DE3726655A1 (no)
DK (1) DK173502B1 (no)
ES (1) ES2047007T3 (no)
FI (1) FI91875C (no)
HU (1) HU198218B (no)
IE (1) IE61557B1 (no)
IL (1) IL87385A (no)
NO (1) NO175004C (no)
NZ (1) NZ225746A (no)
PH (1) PH26874A (no)
PT (1) PT88230B (no)
ZA (1) ZA885871B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG46612A1 (en) 1992-12-02 1998-02-20 Hoechst Ag Process for obtaining proinsulin in processing correctly linked cystine bridges
DE59711533D1 (de) 1996-07-26 2004-05-27 Aventis Pharma Gmbh Insulinderivate mit erhöhter Zinkbindung
DE19652713C2 (de) * 1996-12-18 2001-11-22 Aventis Pharma Gmbh Verfahren zur Reinigung von Insulin und Insulinderivaten durch Chromatographie an stark saurem Kationenaustauscher
KR100341297B1 (ko) * 1997-03-29 2002-11-16 주식회사종근당 재조합활성형프로인슐린의분리.정제방법
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
US6444788B1 (en) * 1999-03-15 2002-09-03 Novo Nordisk A/S Ion exchange chromatography of GLP-1, analogs and derivatives thereof
US6451987B1 (en) * 1999-03-15 2002-09-17 Novo Nordisk A/S Ion exchange chromatography of proteins and peptides
ATE509028T1 (de) * 1999-03-15 2011-05-15 Novo Nordisk As Ionen-austausch-chromatographische trennung von glp-1 und verwandten peptiden
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
DE10235168A1 (de) 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
SE0300791D0 (sv) * 2003-03-20 2003-03-20 Amersham Biosciences Ab Use of ph-responsive polymers
BRPI0413644A (pt) * 2003-08-21 2006-10-17 Novo Nordisk As métodos para separar as duas formas de um polipeptìdeo tendo uma única racemização de aminoácido, e para separar dois polipeptìdeos, produto de polipeptìdeo, e, composição farmacêutica
CN101282880B (zh) * 2005-08-04 2012-12-05 东洋制罐株式会社 塑料瓶灭菌方法
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
KR101853606B1 (ko) 2009-07-06 2018-05-03 사노피-아벤티스 도이칠란트 게엠베하 메티오닌을 함유하는 수성 인슐린 제제
FR2947818B1 (fr) * 2009-07-09 2011-07-29 Inst Superieur Des Sciences Agronomiques Agroalimentaires Horticoles Et Du Paysage Agro Campus Ouest Utilisation d'un coproduit issu d'un procede d'extraction du lysozyme a partir de blanc d'oeuf, pour l'obtention d'au moins une proteine basique de blanc d'oeuf
KR101337322B1 (ko) 2009-11-13 2013-12-06 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
DK2498802T3 (en) 2009-11-13 2015-04-13 Sanofi Aventis Deutschland Pharmaceutical composition comprising a GLP-1 agonist, insulin and a methionine
ES2606554T3 (es) 2010-08-30 2017-03-24 Sanofi-Aventis Deutschland Gmbh Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PL2750699T3 (pl) 2011-08-29 2015-12-31 Sanofi Aventis Deutschland Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
DK2748181T3 (en) * 2011-09-30 2016-05-23 Ge Healthcare Bioprocess R&D Ab PROCEDURE FOR CLEANING THE CLEANED PRO-INSULIN
US10421795B2 (en) * 2012-12-17 2019-09-24 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
WO2015138548A1 (en) 2014-03-14 2015-09-17 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
AU2015359376B2 (en) 2014-12-12 2021-09-09 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
EP3581578A4 (en) * 2017-02-10 2020-04-22 Mitsubishi Chemical Corporation Separating agent for human insulin purification and human insulin purification method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2629568C3 (de) * 1976-07-01 1981-09-10 Hoechst Ag, 6000 Frankfurt Verfahren zur Reinigung von Insulin, seinen Analogen und Derivaten
NL7713966A (nl) * 1976-12-27 1978-06-29 Univ Minnesota Werkwijze voor het behandelen van insuline.
DK311477A (da) * 1977-07-08 1979-01-09 Leo Lab Fremgangsmaade ved fremstilling af rent insulin
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
DE3486216T2 (de) * 1983-04-25 1994-02-17 Chiron Corp Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren.
DE3440988A1 (de) * 1984-11-09 1986-07-10 Hoechst Ag, 6230 Frankfurt Verfahren zur spaltung von peptiden und proteinen an der methionyl-bindung
DE3511269A1 (de) * 1985-04-12 1986-10-09 Veb Berlin-Chemie, Ddr 1199 Berlin Verfahren zur reinigung von insulin
JPS6379591A (ja) * 1986-09-22 1988-04-09 Mitsui Toatsu Chem Inc ｔＰＡの精製方法
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
ES2064412T3 (es) * 1988-10-26 1995-02-01 American Cyanamid Co Procedimiento para reducir el contenido de aglomerado de materiales tipo hormona del crecimiento.

Also Published As

Publication number Publication date
FI883708A0 (fi) 1988-08-09
AU2059188A (en) 1989-02-16
PH26874A (en) 1992-11-16
FI883708L (fi) 1989-02-12
DE3726655A1 (de) 1989-02-23
EP0305760A2 (de) 1989-03-08
IL87385A0 (en) 1989-01-31
EP0305760A3 (en) 1990-06-06
NO175004C (no) 1994-08-17
ZA885871B (en) 1989-04-26
NO883554D0 (no) 1988-08-10
EP0305760B1 (de) 1993-10-27
NZ225746A (en) 1990-11-27
AU609170B2 (en) 1991-04-26
HU198218B (en) 1989-08-28
DE3885214D1 (de) 1993-12-02
US5101013A (en) 1992-03-31
PT88230B (pt) 1995-03-01
FI91875B (fi) 1994-05-13
KR0129539B1 (ko) 1998-04-04
JP2587867B2 (ja) 1997-03-05
KR890003799A (ko) 1989-04-18
IL87385A (en) 1993-08-18
CA1340237C (en) 1998-12-15
JPS6486896A (en) 1989-03-31
DK447688D0 (da) 1988-08-10
PT88230A (pt) 1989-06-30
HUT47958A (en) 1989-04-28
ES2047007T3 (es) 1994-02-16
IE882441L (en) 1989-02-11
FI91875C (fi) 1994-08-25
IE61557B1 (en) 1994-11-16
NO175004B (no) 1994-05-09
DK447688A (da) 1989-02-12
DK173502B1 (da) 2001-01-08
ATE96447T1 (de) 1993-11-15

Similar Documents

Publication Publication Date Title
NO883554D0 (no) Fremgangsmaate til isolering av basiske proteiner fra proteinblandinger som inneholder slike basiske proteiner.
NO883073D0 (no) 3-desmetyl-mevalonsyrederivater, fremgangsmaate til deres fremstilling samt deres anvendelse som mellomprodukter.
DK165988C (da) Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c
NO833942L (no) Beta-karboliner, fremgangsmaate til deres fremstilling og farmasoeytiske preparater som inneholder dem
NO823674L (no) Derivater av cis, endo-2-azabicyklo-(3.3.0)-oktan-3-3-karboksylsyrer, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse
DK552684D0 (da) Desulfatohirudiner samt deres fremstilling og anvendelse
DK250181A (da) Fremgangsmaade til fremstilling af vinblastinderivater
DK346783A (da) Triphenylimidazolyloxyalkansyrer og derivater deraf, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse forbindelser
NO921382D0 (no) Amidinofenylalaninderivater, samt fremstilling, anvendelse og preparater inneholdende forbindelsene
LV10490A (lv) DNS seciba kas kode proteinus ar HUSI-tipa inhibitoru biologisko aktivitati mineto proteinu iegusanas biotehnologiskais panemiens farmaceitiskas kompozicijas kas satur minetos proteinus
DK383388A (da) 3-demethyl-4-fluor-mevalonsyrederivater, deres fremstilling, farmaceutiske praeparater deraf, deres anvendelse og mellemprodukter til deres fremstilling
DK319384D0 (da) 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
NO881111L (no) Fremgangsmaate til isolering av basalmembranproteiner fra menneskelige og dyriske vev.
DK119082A (da) Phosphor(phosphon)-syreesteramider,fremgangsmaade til fremstilling heraf samt deres anvendelse som midler til bekaempelse afskadelige organismer
ES555393A0 (es) Procedimiento para preparar compuestos dimeros de derivados de aminoacidos.
NO167813C (no) Fremgangsmaate for fremstilling av carboxylgruppeholdige polyamider, og anvendelse av disse som lakkbindemiddel.
NO820618L (no) 7-acylamido-3-cefem-4-karboksylsyreforbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder disse forbindelser og anvendelse av sistnevnte
DK194583D0 (da) Thiadiazolylimidazolidinonderivater, deres fremstilling og anvendelse som herbicider og vaekstregulerende midler samt (dialkoxy)-ethylthiadiazolylurinstofudgangsmaterialer til fremstillingen
DK147384A (da) 7,8,9,10-tetrahydrothieno(3,2-e)pyrido(4,3-b)indoler, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
ES531495A0 (es) Procedimiento para preparar un hidrolizado proteinico
Kristoffersen et al. Identification of 20β-Hydroxy-pregn-4-ene-3-one in Luteal Tissue from Pregnant Whales
NO880479L (no) Smaa peptider som hindrer binding til t4-reseptorer og virker som immunorganer, fremgangsmaaten til deres fremstilling og anvendelse av slike peptider.
NO831593L (no) Derivater av cis, endo-2-azabiscyklo-(3.3.0)-oktan-3-karboksylsyre, fremgangsmaate til deres fremstilling, midler som inneholder disse samt deres anvendelse
ES8701149A1 (es) Procedimiento para la preparacion de alfa-aminoacidos alfa- alenicos
DK551183A (da) Substituerede 9h-8-oxo-pyrimido(2,1-f)purin-2,4-dioner, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne

Legal Events

Date Code Title Description
MK1K Patent expired